Evidence map›Paper›PMID 36395254›Full record

ArticlePloS one2022

Covid-19 vaccines in Italian public opinion: Identifying key issues using Twitter and Natural Language Processing.

Luisa Stracqualursi, Patrizia Agati

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Luisa StracqualursiDepartment of Statistics, University of Bologna, Bologna, BO, Italy.ORCID 0000-0002-8022-1377
Patrizia AgatiDepartment of Statistics, University of Bologna, Bologna, BO, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has changed society and people's lives. The vaccination campaign started December 27th 2020 in Italy, together with most countries in the European Union. Social media platforms can offer relevant information about how citizens have experienced and perceived the availability of vaccines and the start of the vaccination campaign. This study aims to use machine learning methods to extract sentiments and topics relating to COVID-19 vaccination from Twitter. Between February and May 2021, we collected over 71,000 tweets containing vaccines-related keywords from Italian Twitter users. To get the dominant sentiment throughout the Italian population, spatial and temporal sentiment analysis was performed using VADER, highlighting sentiment fluctuations strongly influenced by news of vaccines' side effects. Additionally, we investigated the opinions of Italians with respect to different vaccine brands. As a result, 'Oxford-AstraZeneca' vaccine was the least appreciated among people. The application of the Dynamic Latent Dirichlet Allocation (DLDA) model revealed three fundamental topics, which remained stable over time: vaccination plan info, usefulness of vaccinating and concerns about vaccines (risks, side effects and safety). To the best of our current knowledge, this one the first study on Twitter to identify opinions about COVID-19 vaccination in Italy and their progression over the first months of the vaccination campaign. Our results can help policymakers and research communities track public attitudes towards COVID-19 vaccines and help them make decisions to promote the vaccination campaign.

Indexed as

COVID-19COVID-19 VaccinesSocial MediaHumansNatural Language ProcessingPandemicsPapillomavirus VaccinesPublic OpinionCOVID-19 VaccinesPapillomavirus Vaccines

Identifiers

PMID36395254
PMCPMC9671418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.